Authors
Latest:
Mitigating the Effects of Ongoing Drug ShortagesThe ability—or lack thereof—to procure drugs can drive prices up and decrease patient accessibility.
Latest:
Introducing Tarlatamab-dlle: A New Era in Oncology TreatmentThe therapy offers new hope in solid tumor treatment with fewer adverse effects.
Latest:
Introducing Tarlatamab-dlle: A New Era in Oncology TreatmentThe therapy offers new hope in solid tumor treatment with fewer adverse effects.
Latest:
Embracing Digital Transformation: How Pharmacies Can Thrive in an Evolving Health Care LandscapePharmacies can adapt by embracing digital self-service options to better engage with patients, meet increasing consumer demand, and enhance revenue streams.
Latest:
Chronic Lymphocytic Leukemia: A Review of Noncovalent BTK Inhibitors, Novel Agents, and Toxicity Management of BTK InhibitorsThis article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.
Latest:
Medication Therapy Management: How Pharmacists Are Personalizing Patient CarePharmacists have developed an expanded role in the team-based approach through medication therapy management.
Latest:
Clinical Overview: Certain Antihypertensive Drugs Can Lower Risk for New Onset Type 2 DiabetesMeta-analysis of randomized controlled trials adds to growing evidence around certain antihypertensive drug classes showing promise for primary or secondary prevention of diabetes.
Latest:
Revolutionizing Outpatient Oncology Care: The Seamless Integration of Artificial IntelligenceArtificial intelligence holds immense potential to address the rising demand for oncology services and improve patient outcomes by facilitating more effective, efficient, personalized cancer care.
Latest:
Redefining Pharmacovigilance Through Digital InnovationAI is revolutionizing pharmacovigilance by enhancing data analysis, improving patient safety, and enabling proactive risk management in drug monitoring.
Latest:
A Pharmacist’s View of Emerging CML TreatmentA panelist discusses how emerging chronic myeloid leukemia treatment advancements, including the addition of asciminib as a frontline tyrosine kinase inhibitor (TKI) option and ongoing research into dual TKI therapy and optimal dosing strategies, are expanding therapeutic choices while pharmacists play a key role in educating patients and providers about evolving treatment algorithms, evaluating new literature, and helping teams manage newer agents with less clinical experience.
Latest:
So-Called “Ozempic Babies” Raise Questions About Unintended Effects of GLP-1 AgonistsAs of now, data suggest minimal risk of drug interactions between oral contraceptives and injectable semaglutide.
Latest:
Proof of Delivery is Key to Maximizing Pharmacy Reimbursement, Defending Audits and Preventing Costly Write-OffsFive crucial steps pharmacies can take to enhance patient engagement and lower operational costs.
Latest:
Exploring the Antidepressant Potential of GLP-1 Receptor AgonistsGLP-1 receptor agonists show promise in alleviating depressive symptoms in patients with type 2 diabetes, offering a potential dual benefit in treatment.
Latest:
Concerns of the At-Home FluMist Emphasize Need for Patient Safety, Proper AdministrationIssues around patient safety, proper administration, and monitoring need careful consideration from pharmacists and other health care providers for vaccination efforts.
Latest:
Real-World Data on Expanding Step-Up Dosing Administration of Bispecific T-Cell Engagers in the Outpatient SettingThis abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Latest:
Claims, Lab, and EHR Data Can Make or Break a Drug LaunchReal-world data can help resolve access barriers by providing a highly detailed view into the barriers that impact specific patient populations.
Latest:
Considerations for Environmentally Conscious Pharmacy StudentsEnvironmental conditions and air pollution affect health by causing injuries and fatalities, exacerbating respiratory and cardiovascular diseases, and spreading infectious diseases.
Latest:
Revolutionizing Treatment with Bispecific Therapies: Navigating the Challenges AheadBy decade’s end, approval of additional bispecifics is expected for hematological malignancies, solid tumors, and non-oncology conditions such as inflammatory, autoimmune, neurodegenerative and vascular diseases, and ocular disorders and infections.
Latest:
Improving Medication Reconciliation Accuracy in a Primary Care PracticeAccurate medication reconciliations are critical for ensuring safe patient outcomes, and a correct medication list can help prevent drug-drug interactions, contraindications, and duplicate therapies.
Latest:
Expert: Dual Interaction is Present Between Epilepsy and MenopausePaula E. Voinescu, PhD, MD, emphasized the need for additional research in this area, noting it is both “surprising and upsetting.”
Latest:
Ashwagandha: A Case Example of the Supplement IndustryPerhaps ashwagandha may aid in stress management, athletic performance, and sleep, but this effect is far from definitive.
Latest:
Psychiatric Medication Adherence in Patients Experiencing HomelessnessUnique barriers can lead to psychiatric medication adherence rates as low as 26%.
Latest:
Study: Developing MIS-C Remains Rare but Significantly More Likely for Unvaccinated ChildrenStudy shows that 98% of cases of multi-system inflammatory syndrome in children (MIS-C) were unvaccinated, suggesting that vaccination reduces the chance of a child who had COVID-19 later developing MIS-C.
Latest:
Managing Drug Interactions in HIV and TB Coinfection Is ComplexBest practices call for referring to resources, such as those from HHS and the University of Liverpool.
Latest:
Understanding the FDA Approval Process and PDUFA DatesThe FDA reviews NDAs and BLAs to approve medications for sale and marketing in the US with decisions required by the PDUFA date.
Latest:
Deprescribing Helps Optimize Medication UseFrequent reassessments of therapy regimens address polypharmacy, particularly for older patients.
Latest:
Targeting a Newly Identified Gene in the Brain May Reduce AnxietyAnxiety disorders create social and economic burdens as the availability of effective anxiolytic treatments are low.
Latest:
Enhancing Patient Care and the Scope of Practice for Pharmacists, Student Pharmacists Through Immunizations During the Monkeypox OutbreakPharmacists and student pharmacists became the center of responding to the Monkeypox outbreak by providing immunizations to their communities.
